These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5721657)

  • 1. Passive hemagglutination studies with snake venom and antivenin.
    Boche RD; Russell FE
    Toxicon; 1968 Oct; 6(2):125-30. PubMed ID: 5721657
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous antivenin in clinical snake venom poisoning. A preliminary report.
    PARRISH HM
    Mo Med; 1963 Mar; 60():240-4. PubMed ID: 13941591
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies of cross protection between sera and venoms of the most common species of Mexican snakes].
    Pérez de la Mora S; Pérez-Miravete A; García Pérez G
    Rev Invest Salud Publica; 1972; 32(3-4):145-57. PubMed ID: 4208266
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of passive haemagglutination (PHA) and haemagglutination inhibition (HAI) technique for potency estimation of Cobra Antisnake Venom Serum (ASVS).
    Pradhan S; Kumar S; Singh D; Sood RC; Sehgal R
    Biologicals; 2007 Jun; 35(3):155-60. PubMed ID: 17088076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous antivenin in neutralization of North American coral snake venom.
    KEEGAN HL; WHITTEMORE FW; FLANIGAN JF
    Public Health Rep (1896); 1961 Jun; 76(6):540-2. PubMed ID: 13752144
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative studies on the effectiveness of an antivenin and its fractions.
    Timmerman WF; Russell FE
    Toxicon; 1969 May; 6(4):311-4. PubMed ID: 5805127
    [No Abstract]   [Full Text] [Related]  

  • 7. Reverse passive hemagglutination tests for rapid diagnosis of snake envenomation.
    Kittigul L; Ratanabanangkoon K
    J Immunoassay; 1993 Sep; 14(3):105-27. PubMed ID: 8354715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyvalent antivenin in treatment of experimental snake venom poisoning.
    MINTON SA
    Am J Trop Med Hyg; 1954 Nov; 3(6):1077-82. PubMed ID: 13207562
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological properties of antivenins. I. Bivalent Cerastes cerastes and Cerastes vipera antivenin.
    Hassan F; El-Hawary MF
    Am J Trop Med Hyg; 1975 Nov; 24(6 Pt 1):1031-4. PubMed ID: 812369
    [No Abstract]   [Full Text] [Related]  

  • 10. Snake and spider antivenin: risks and benefits of therapy.
    Weisman RS; Lizarralde SS; Thompson V
    J Fla Med Assoc; 1996 Mar; 83(3):192-5. PubMed ID: 8920051
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paraspecificity of antivenins: example of severe envenomation by the Sahara horned viper (Cerastes cerastes) treated with non-specific antivenin].
    Aissaoui Y; Kichna H; Boughalem M; Drissi Kamili N
    Med Sante Trop; 2013; 23(1):100-3. PubMed ID: 23695188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice.
    Consroe P; Egen NB; Russell FE; Gerrish K; Smith DC; Sidki A; Landon JT
    Am J Trop Med Hyg; 1995 Nov; 53(5):507-10. PubMed ID: 7485708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of snake venoms in tissue fluids.
    Coulter AR; Sutherland SK; Broad AJ
    J Immunol Methods; 1974 Mar; 4(2):297-300. PubMed ID: 4857069
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation and standardization of toxoid from the venom of Trimeresurus flavoviridis (Habu).
    Kondo S; Sadahiro S; Yamauchi K; Kondo H; Murata R
    Jpn J Med Sci Biol; 1971 Oct; 24(5):281-94. PubMed ID: 5316782
    [No Abstract]   [Full Text] [Related]  

  • 15. [Snake venoms. 2. The chemical constitution of snake venoms and immunity against venoms].
    Boquet P
    Toxicon; 1966 Apr; 3(4):243-79. PubMed ID: 5332593
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of antivenin prepared from goat serum.
    Russell FE; Timmerman WF; Meadows PE
    Toxicon; 1970 May; 8(1):63-5. PubMed ID: 5465748
    [No Abstract]   [Full Text] [Related]  

  • 17. Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming.
    Gutiérrez JM; Lomonte B; León G; Alape-Girón A; Flores-Díaz M; Sanz L; Angulo Y; Calvete JJ
    J Proteomics; 2009 Mar; 72(2):165-82. PubMed ID: 19344652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and toxological problems in poisonous snake bites].
    Scholer H; Wüthrich W
    Schweiz Med Wochenschr; 1970 Oct; 100(42):1761-6. PubMed ID: 5480546
    [No Abstract]   [Full Text] [Related]  

  • 19. Further studies on the immunogenic properties of photooxidized Formosan snake venoms, with special reference to a trial preparation of polyvalent antivenin using photooxidized multiple venom antigens--second report.
    Huang CT; Huang JS; Ling KH; Lin SY
    Taiwan Yi Xue Hui Za Zhi; 1973 Apr; 72(4):208-17. PubMed ID: 4515138
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects on phospholipase A2 and antivenin activity of melanin extracted from Thea sinensis Linn.
    Hung YC; Sava V; Hong MY; Huang GS
    Life Sci; 2004 Mar; 74(16):2037-47. PubMed ID: 14967198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.